International Journal of Advances in Science, Engineering and Technology(IJASEAT)
.
Follow Us On :
current issues
Volume-9,Issue-3  ( Jul, 2021 )
Statistics report
Dec
Submitted Papers : 80
Accepted Papers : 10
Rejected Papers : 70
Acc. Perc : 12%
  Journal Paper


Paper Title :
Cell Growth Inhibition and Cytotoxicity of 5-Aza-Cytidine on Cisplatin-Resistant Neuroblastoma Cells

Author :Fangyu Peng, Harold C. Simmons

Article Citation :Fangyu Peng ,Harold C. Simmons , (2018 ) " Cell Growth Inhibition and Cytotoxicity of 5-Aza-Cytidine on Cisplatin-Resistant Neuroblastoma Cells " , International Journal of Advances in Science, Engineering and Technology(IJASEAT) , pp. 52-55, Volume-6, Issue-4, Spl. Iss-2

Abstract : Neuroblastoma (NB) is a malignant tumor of the peripheral sympathetic nervous system in children, accounting for 8% to 10% of all childhood cancers. Cisplatin is a potent anticancer drug highly cytotoxic to NB cells, but clinical use of cisplatin for treatment of NB was limited by side effects and acquired cisplatin-resistance of NB cells. To develop new drugs for treatment of cisplatin-resistant NB, this study aimed to test anticancer activity of 5-Aza-cytidine, a DNA methyltransferase inhibitor, on cisplatin-resistant NB cells. The experimental results of this study demonstrated cell growth inhibition and cytotoxicity of 5’-aza-cytidine on cisplatin-resistant NB cells. Moreover, reduced expression of DNMT1 was detected in the NB cells treated with 5’-aza-cytidine by immunoblot assay. The findings from this study support further study of 5’-aza-cytidine as a promising drug for treatment of cisplatin-resistant NB in children. Keywords - Neuroblastoma, 5-Aza-Cytidine, DNA Methyltransferase, 18F-FDG

Type : Research paper

Published : Volume-6, Issue-4, Spl. Iss-2


DOIONLINE NO - IJASEAT-IRAJ-DOIONLINE-14811   View Here

Copyright: © Institute of Research and Journals

| PDF |
Viewed - 13
| Published on 2019-03-21
   
   
IRAJ Other Journals
IJASEAT updates
Volume-9,Issue-2(April, 2020)
The Conference World

JOURNAL SUPPORTED BY